How the Narrative Around Roche Is Evolving Amid Analyst Updates and Clinical Shifts [Yahoo! Finance]
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: Yahoo! Finance
This change follows analyst updates that reflect a balance of positive developments, such as promising clinical trial outcomes and strategic partnerships, alongside persistent concerns over competition and mixed data. To understand how these shifts might impact Roche's narrative and future prospects, stay tuned for ways to keep informed as the story evolves. Stay updated as the Fair Value for Roche Holding shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Roche Holding. What Wall Street Has Been Saying Recent commentary from analysts provides a nuanced view of Roche Holding's current position and future prospects. Insights from several firms illustrate both optimistic and cautious perspectives, which collectively inform the stock's valuation and outlook. ?? Bullish Takeaways Some analysts see strategic momentum and execution, especially following positive clinical results and recent partnerships. Needham
Show less
Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- Roche (OTCMKTS:RHHBY) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.MarketBeat
- Roche receives FDA clearance with CLIA waiver and CE Mark for its first point-of-care test for diagnosing Bordetella infections, including whooping cough (pertussis) [Yahoo! Finance]Yahoo! Finance
- Flatiron Health announces research to be presented at the 2025 San Antonio Breast Cancer Symposium [Yahoo! Finance]Yahoo! Finance
- Flatiron Health announces research to be presented at the 2025 San Antonio Breast Cancer SymposiumBusiness Wire
- Roche shares hit milestone with 19% November surge on breast cancer and promising MS drug trials [Seeking Alpha]Seeking Alpha